Currently submitted to: JMIR Formative Research
Date Submitted: Jun 2, 2026
Open Peer Review Period: Jun 3, 2026 - Jul 29, 2026
(currently open for review)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Prediction of Future Spinal Cord Stimulation Pathway Entry in Persistent Spinal Pain After Spine Surgery: Index and 90-Day Landmark Referral-Support Models
ABSTRACT
Background:
Background:
Patients with persistent spinal pain after spine surgery may undergo prolonged medication escalation and repeated procedures before referral for spinal cord stimulation (SCS) or neuromodulation evaluation.
Objective:
Objective:
To develop and internally evaluate referral-support models for future SCS/neuromodulation documentation among patients with failed back surgery syndrome/persistent spinal pain syndrome type 2 in a tertiary pain clinic.
Methods:
Methods:
We performed a retrospective patient-level electronic health-record analysis using two prespecified horizons. The index model used features available at or before the earliest FBSS/post-spine-surgery pain-clinic presentation. The 90-day landmark model used features accumulated within the first 90 days of tertiary pain-clinic care. Penalized logistic regression was the primary model; random forest and histogram gradient boosting were exploratory. Leakage-prone future variables, no-variance predictors, and exact duplicates were excluded. Performance was assessed using AUROC, AUPRC, Brier score, calibration, threshold metrics, feature importance, and decision curves.
Results:
Results:
The index cohort included 572 patients; 116 (20.3%) had future SCS/neuromodulation documentation. The primary index model achieved random test AUROC 0.633 (95% CI, 0.476-0.772), AUPRC 0.310, and Brier score 0.161. The 90-day landmark cohort included 557 patients; 101 (18.1%) had future SCS documentation. The primary 90-day model achieved random test AUROC 0.772 (95% CI, 0.636-0.876), AUPRC 0.423, and Brier score 0.129. Temporal tests were underpowered, with only 10 and 6 events.
Conclusions:
Conclusions:
A 90-day landmark referral-support model demonstrated encouraging internal random-test performance for future SCS pathway entry, but external and prospective validation are required before workflow implementation.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.